Literature DB >> 26503046

Crystal structure of the RNA-dependent RNA polymerase from influenza C virus.

Narin Hengrung1,2, Kamel El Omari2, Itziar Serna Martin1, Frank T Vreede1, Stephen Cusack3, Robert P Rambo4, Clemens Vonrhein5, Gérard Bricogne5, David I Stuart2,4, Jonathan M Grimes2,4, Ervin Fodor1.   

Abstract

Negative-sense RNA viruses, such as influenza, encode large, multidomain RNA-dependent RNA polymerases that can both transcribe and replicate the viral RNA genome. In influenza virus, the polymerase (FluPol) is composed of three polypeptides: PB1, PB2 and PA/P3. PB1 houses the polymerase active site, whereas PB2 and PA/P3 contain, respectively, cap-binding and endonuclease domains required for transcription initiation by cap-snatching. Replication occurs through de novo initiation and involves a complementary RNA intermediate. Currently available structures of the influenza A and B virus polymerases include promoter RNA (the 5' and 3' termini of viral genome segments), showing FluPol in transcription pre-initiation states. Here we report the structure of apo-FluPol from an influenza C virus, solved by X-ray crystallography to 3.9 Å, revealing a new 'closed' conformation. The apo-FluPol forms a compact particle with PB1 at its centre, capped on one face by PB2 and clamped between the two globular domains of P3. Notably, this structure is radically different from those of promoter-bound FluPols. The endonuclease domain of P3 and the domains within the carboxy-terminal two-thirds of PB2 are completely rearranged. The cap-binding site is occluded by PB2, resulting in a conformation that is incompatible with transcription initiation. Thus, our structure captures FluPol in a closed, transcription pre-activation state. This reveals the conformation of newly made apo-FluPol in an infected cell, but may also apply to FluPol in the context of a non-transcribing ribonucleoprotein complex. Comparison of the apo-FluPol structure with those of promoter-bound FluPols allows us to propose a mechanism for FluPol activation. Our study demonstrates the remarkable flexibility of influenza virus RNA polymerase, and aids our understanding of the mechanisms controlling transcription and genome replication.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26503046      PMCID: PMC4783868          DOI: 10.1038/nature15525

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  43 in total

1.  EMBOSS: the European Molecular Biology Open Software Suite.

Authors:  P Rice; I Longden; A Bleasby
Journal:  Trends Genet       Date:  2000-06       Impact factor: 11.639

2.  3D structure of the influenza virus polymerase complex: localization of subunit domains.

Authors:  Estela Area; Jaime Martín-Benito; Pablo Gastaminza; Eva Torreira; José M Valpuesta; José L Carrascosa; Juan Ortín
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

3.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

4.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

5.  Comparative analysis of the ability of the polymerase complexes of influenza viruses type A, B and C to assemble into functional RNPs that allow expression and replication of heterotypic model RNA templates in vivo.

Authors:  B Crescenzo-Chaigne; N Naffakh; S van der Werf
Journal:  Virology       Date:  1999-12-20       Impact factor: 3.616

6.  Crucial role of CA cleavage sites in the cap-snatching mechanism for initiating viral mRNA synthesis.

Authors:  Ping Rao; Weiming Yuan; Robert M Krug
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

7.  Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding.

Authors:  Pierre Fechter; Louise Mingay; Jane Sharps; Anna Chambers; Ervin Fodor; George G Brownlee
Journal:  J Biol Chem       Date:  2003-03-19       Impact factor: 5.157

8.  A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs.

Authors:  Ervin Fodor; Mandy Crow; Louise J Mingay; Tao Deng; Jane Sharps; Pierre Fechter; George G Brownlee
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Role of the influenza virus heterotrimeric RNA polymerase complex in the initiation of replication.

Authors:  Tao Deng; Jane L Sharps; George G Brownlee
Journal:  J Gen Virol       Date:  2006-11       Impact factor: 3.891

10.  A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization.

Authors:  Thomas S Walter; Jonathan M Diprose; Chris J Mayo; Christian Siebold; Mike G Pickford; Lester Carter; Geoff C Sutton; Nick S Berrow; James Brown; Ian M Berry; Guillaume B E Stewart-Jones; Jonathan M Grimes; David K Stammers; Robert M Esnouf; E Yvonne Jones; Ray J Owens; David I Stuart; Karl Harlos
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-05-26
View more
  76 in total

1.  Firefly genomes illuminate parallel origins of bioluminescence in beetles.

Authors:  Timothy R Fallon; Sarah E Lower; Ching-Ho Chang; Manabu Bessho-Uehara; Gavin J Martin; Adam J Bewick; Megan Behringer; Humberto J Debat; Isaac Wong; John C Day; Anton Suvorov; Christian J Silva; Kathrin F Stanger-Hall; David W Hall; Robert J Schmitz; David R Nelson; Sara M Lewis; Shuji Shigenobu; Seth M Bybee; Amanda M Larracuente; Yuichi Oba; Jing-Ke Weng
Journal:  Elife       Date:  2018-10-16       Impact factor: 8.140

2.  AZT acts as an anti-influenza nucleotide triphosphate targeting the catalytic site of A/PR/8/34/H1N1 RNA dependent RNA polymerase.

Authors:  Nataraj Sekhar Pagadala
Journal:  J Comput Aided Mol Des       Date:  2019-02-09       Impact factor: 3.686

3.  Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors.

Authors:  Alexander Pflug; Stephanie Gaudon; Patricia Resa-Infante; Mathilde Lethier; Stefan Reich; Wiebke M Schulze; Stephen Cusack
Journal:  Nucleic Acids Res       Date:  2018-01-25       Impact factor: 16.971

4.  Structural Biology of the Arterivirus nsp11 Endoribonucleases.

Authors:  Manfeng Zhang; Xiaorong Li; Zengqin Deng; Zhenhang Chen; Yang Liu; Yina Gao; Wei Wu; Zhongzhou Chen
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

5.  Insight into the multifunctional RNA synthesis machine of rabies virus.

Authors:  Ervin Fodor
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-28       Impact factor: 11.205

6.  Development and Characterization of a Reverse-Genetics System for Influenza D Virus.

Authors:  Jieshi Yu; Runxia Liu; Bin Zhou; Tsui-Wen Chou; Elodie Ghedin; Zizhang Sheng; Rongyuan Gao; Shao-Lun Zhai; Dan Wang; Feng Li
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

7.  Influenza virus polymerase subunits co-evolve to ensure proper levels of dimerization of the heterotrimer.

Authors:  Kuang-Yu Chen; Emmanuel Dos Santos Afonso; Vincent Enouf; Catherine Isel; Nadia Naffakh
Journal:  PLoS Pathog       Date:  2019-10-03       Impact factor: 6.823

8.  Differential Splicing of ANP32A in Birds Alters Its Ability to Stimulate RNA Synthesis by Restricted Influenza Polymerase.

Authors:  Steven F Baker; Mitchell P Ledwith; Andrew Mehle
Journal:  Cell Rep       Date:  2018-09-04       Impact factor: 9.423

9.  Structural insight into arenavirus replication machinery.

Authors:  Ruchao Peng; Xin Xu; Jiamei Jing; Min Wang; Qi Peng; Sheng Liu; Ying Wu; Xichen Bao; Peiyi Wang; Jianxun Qi; George F Gao; Yi Shi
Journal:  Nature       Date:  2020-03-18       Impact factor: 49.962

Review 10.  Structure and Function of the Influenza Virus Transcription and Replication Machinery.

Authors:  Ervin Fodor; Aartjan J W Te Velthuis
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.